<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Q</submitter><funding>NEI NIH HHS</funding><funding>National Eye Institute</funding><funding>Research to Prevent Blindness</funding><funding>National Institutes of Health</funding><funding>Babraham Institute</funding><pagination>116046</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12439348</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(8)</volume><pubmed_abstract>Although the regulation of branching morphogenesis by spatially distributed cues is well established, the underlying intracellular signaling mechanisms are not well understood. The development of the lacrimal gland is driven by fibroblast growth factor (FGF) signaling, which activates phospholipase C gamma (PLCγ). Here, we showed that mutating the PLCγ1 binding site on Fgfr2 leads to ectopic branching and hyperplasia in the lacrimal gland, which was phenocopied by either deleting PLCγ1 or disabling any of its SH2 domains. PLCγ1 inactivation did not change the level of Fgfr2 or affect mitogen-activated protein kinase (MAPK) signaling but instead led to sustained AKT phosphorylation due to increased phosphatidylinositol 3,4,5-trisphosphate (PIP3) production. Consistent with this, the PLCγ1 m</pubmed_abstract><journal>Cell reports</journal><pubmed_title>FGF-induced phospholipase Cγ signaling regulates lacrimal gland branching by competing with PI3K in phosphoinositide metabolism.</pubmed_title><pmcid>PMC12439348</pmcid><funding_grant_id>R01 EY034451</funding_grant_id><funding_grant_id>P30 EY019007</funding_grant_id><funding_grant_id>R01 EY018868</funding_grant_id><funding_grant_id>R01EY031210</funding_grant_id><funding_grant_id>K99EY032171</funding_grant_id><funding_grant_id>R01EY018868</funding_grant_id><funding_grant_id>R01 EY031210</funding_grant_id><funding_grant_id>BB/Y0006925/1</funding_grant_id><funding_grant_id>K99 EY032171</funding_grant_id><funding_grant_id>5P30EY019007</funding_grant_id><funding_grant_id>R01EY034451</funding_grant_id><pubmed_authors>Hannan A</pubmed_authors><pubmed_authors>Stephens L</pubmed_authors><pubmed_authors>Tao C</pubmed_authors><pubmed_authors>Anderson KE</pubmed_authors><pubmed_authors>Peregrin J</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Makrides N</pubmed_authors><pubmed_authors>Lin CS</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Hawkins P</pubmed_authors><pubmed_authors>Ding Z</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>FGF-induced phospholipase Cγ signaling regulates lacrimal gland branching by competing with PI3K in phosphoinositide metabolism.</name><description>Although the regulation of branching morphogenesis by spatially distributed cues is well established, the underlying intracellular signaling mechanisms are not well understood. The development of the lacrimal gland is driven by fibroblast growth factor (FGF) signaling, which activates phospholipase C gamma (PLCγ). Here, we showed that mutating the PLCγ1 binding site on Fgfr2 leads to ectopic branching and hyperplasia in the lacrimal gland, which was phenocopied by either deleting PLCγ1 or disabling any of its SH2 domains. PLCγ1 inactivation did not change the level of Fgfr2 or affect mitogen-activated protein kinase (MAPK) signaling but instead led to sustained AKT phosphorylation due to increased phosphatidylinositol 3,4,5-trisphosphate (PIP3) production. Consistent with this, the PLCγ1 m</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-01T15:43:29.196Z</modification><creation>2026-04-08T13:42:58.939Z</creation></dates><accession>S-EPMC12439348</accession><cross_references><pubmed>40711883</pubmed><doi>10.1016/j.celrep.2025.116046</doi></cross_references></HashMap>